+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brain



Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brain



British Journal of Pharmacology 157(7): 1225-1231



The chemokine, stromal cell-derived growth factor-1alpha (SDF-1alpha/CXCL12), a member of the CXC chemokine family, and the ligand for CXCR4, the co-receptor involved in the entry of human immunodeficiency virus-1 (HIV-1), was tested for its possible interaction with a physiological response to a cannabinoid. The cannabinoid agonist, an aminoalkylindole, (+)-WIN 55,212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], was infused directly into the preoptic anterior hypothalamus (POAH), the primary brain area involved in thermoregulation. WIN 55,212-2 (5-15 microg) evoked a dose-related hypothermia, which was attenuated by SDF-1alpha/CXCL12 microinjected directly into the POAH. The inhibitory effect of SDF-1alpha/CXCL12 on WIN 55,212-2-induced hypothermia was reversed by 1,1'-[1,4-phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] octohydrobromide dihydrate, an antagonist of SDF-1alpha/CXCL12, acting at its receptor, CXCR4. This study provides the first in vivo evidence for a thermoregulatory interaction between the HIV-1 co-receptor and the cannabinoid system in the brain.

(PDF emailed within 0-6 h: $19.90)

Accession: 055001818

Download citation: RISBibTeXText

PMID: 19558543

DOI: 10.1111/j.1476-5381.2009.00285.x


Related references

Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. Journal of Biological Chemistry 275(1): 605-612, 2000

The localization and physiological effects of cannabinoid receptor 1 in the brain stem auditory system of the chick. Neuroscience 194: 150-159, 2012

The localization and physiological effects of cannabinoid receptor 1 CB1 in the brain stem auditory system of the chick. 2011

Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: Further evidence for cannabinoid CB2 receptor absence in the rat central nervous system. European Journal of Pharmacology 377(1): 117-125, July 14, 1999

Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. Journal of Pharmacology and Experimental Therapeutics 284(3): 1209-1217, 1998

Interaction between orexin A and cannabinoid system in the lateral hypothalamus of rats and effects of subchronic intraperitoneal administration of cannabinoid receptor inverse agonist on food intake and the nutritive utilization of protein. Journal of Physiology and Pharmacology 66(2): 181-190, 2016

A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. Journal of Neuroscience 22(14): 5865-5878, 2002

Interaction of azido delta 8 thc with the cannabinoid receptor in brain. Society for Neuroscience Abstracts 16(1): 524, 1990

First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain. Journal of Pharmacology and Experimental Therapeutics 325(2): 641-645, 2008

Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1alpha: implications for development of selective CXCR4 antagonists. Immunology Letters 78(1): 29-34, 2001

B-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between b-arrestin and CXCR4. The Journal of Biological Chemistry 275(4): 79-85, 2000

Physiological evidence of a postsynaptic inhibition of the tail flick reflex by a cannabinoid receptor agonist. European Journal of Pharmacology 602(1): 36-40, 2009

First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain (vol 325, pg 641, 2008). 2007

Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion. Plos One 6(9): E23901-E23901, 2012